Amendment_2_-_Research_Areas_002_and_003_-_Revised_Receipt_Date.pdf
PDF 92 KB Posted
- Attached to
- 2019 NIAID Omnibus Broad Agency Announcement
- Solicitation number
- HHS-NIH-NIAID-BAA2019-1
About this file
This document is an amendment to a broad agency announcement soliciting proposals for research related to infectious diseases. The amendment revises the proposal receipt dates for two research areas within the solicitation. Research Area 002 regarding the development of therapeutic products for antibiotic resistant bacteria, and Research Area 003 regarding advanced development of vaccine candidates for antibiotic resistant bacteria, now have a revised proposal receipt date of June 10, 2019 at 3:00 PM Eastern Time, extended from the previous date of May 20, 2019. The amendment provides contact information for questions and requires acknowledgement of receipt of the amendment in proposals. The broad agency announcement solicits research proposals for the National Institute of Allergy and Infectious Diseases across multiple research areas involving development of medical countermeasures, therapeutics, and vaccines for infectious diseases and antibiotic resistant bacteria. Estimated available funding, deliverables, and period of performance are defined for each research area. Proposals must be submitted electronically by the specified dates through the designated website portal.
Amendment 2 - Research Areas 002 and 003 - Revision of Proposal Receipt Date
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Amendment #2 Solicitation HHS-NIH-NIAID-BAA2019-1
AMENDMENT TWO (2)
OFFICE OF ACQUISITONS
National Institute of Allergy and Infectious Diseases (NIAID) 5601 Fishers Lane, Room 3D32, MSC 9821 Rockville, MD 20852
Solicitation Number: HHS-NIH-NIAID-BAA2019-1
Date of Solicitation Issuance: 02/22/2019
Date of Amendment No.1 Issuance: 05/01/2019
Date of Amendment No.2 Issuance: 05/09/2019
Number of Pages: 2
Points of Contact:
Division of Allergy, Immunology, and Transplantation (DAIT)
Research Area 001: Development of Radiation/Nuclear Medical Countermeasures
Liem Nguyen, Contracting Officer Phone: (240) 669-5144; E-mail: liem.nguyen@nih.gov
Division of Microbiology and Infectious Diseases (DMID)
Research Area 002: Development of Therapeutic Products for Antibiotic Resistant Bacteria;
Research Area 003: Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
Julie Rodriguez, Contract Specialist Phone: (301) 761-7735; Email: julie.rodriguez@nih.gov
George Kennedy, Contracting Officer Phone: (240) 669-5170; Email: kennedyg@mail.nih.gov
Offerors must acknowledge receipt of the amendment by Amendment number(s) and date of the amendment. Include a statement of acknowledgement in your proposal submission.
Failure of acknowledgement may result in rejection of your offer.
Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
Purpose of Amendment 2: Revision of Proposal Receipt Date and Time
This purpose of this amendment is to revise the proposal receipt date for Research Area 002 and 003 as follows:
Research Area 002, DMID, “Development of Therapeutic Products for Antibiotic Resistant Bacteria”: The date for receipt of proposals is revised from 05/20/2019 to 06/10/2019;
Research Area 003, DMID, “Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria”: The date for receipt of proposals is revised from 05/20/2019 to 06/10/2019.
Accordingly, solicitation Section 4.3.2.1.1 “Receipt Date”, is revised as follows:
Receipt Date
This BAA includes multiple distinct Research Areas, each with a specified closing date and time, identified below. An Offeror must submit a separate and distinct proposal for each Research Area to which it wishes to propose:
RESEARCH
AREA
NIAID
DIVISION
TITLE
RECEIPT DATE
AND TIME:
001 DAIT
Development of Radiation/Nuclear Medical Countermeasures (MCMs)
3:00 PM, Eastern Time, 05/20/2019
002 DMID
Development of Therapeutic Products for Antibiotic Resistant Bacteria
3:00 PM,
Eastern Time, 06/10/2019
003 DMID
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
3:00 PM,
Eastern Time, 06/10/2019
End of Amendment 2
File details come from the government source that posted it. Updated .